Acceleron names new chair of board
This article was originally published in Scrip
Executive Summary
Acceleron Pharma, a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapeutic candidates that regulate cellular growth and repair, has appointed Dr Francois Nader chair of its board of directors. Dr Nader joined the Acceleron board in December 2014. Most recently he was president, CEO and director of NPS Pharma through the recent acquisition of NPS by Shire.